Cohort study of the impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

Cohort study of the impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

Background and Aims: All oral direct-acting antivirals (DAAs) effectively treat chronic hepatitis C virus (HCV) infection, but the benefits in advanced liver disease are unclear. We compared outcomes in treated and untreated patients with decompensated cirrhosis. Methods: Patients with HCV and deco...

Full description

Bibliographic Details
Main Authors: Foster, Graham R., Irving, William L., Cheung, Michelle C.M., Walker, Alex J., Hudson, Benjamin E., Verma, Suman, McLauchlan, John, Mutimer, David J., Brown, Ashley, Gelson, William T.H., MacDonald, Douglas C., Agarwal, Kosh
Format: Article
Published: Elsevier 2016
Online Access:https://eprints.nottingham.ac.uk/32394/

Internet

https://eprints.nottingham.ac.uk/32394/

Similar Items